plus 1,700 comment letters to the FDA generated from ASCP grassroots efforts, opposing the FDA's proposed rule for LDTs.
opposing the CMS proposed rule to add nursing degrees to the CLIA high and moderate complexity testing personnel requirements.
The ASCP Institute for Science, Technology and Policy (ISTP), in conjunction with ASCP commissions, councils, and the board of directors, oversees the development and review of public policies that benefit pathologists, laboratory professionals, and patients.
ASCP is committed to developing public policies that not only improve the public's health through the practice of laboratory medicine, but also represent the interests of its membership.
ASCP proactively identifies and develops programs and special efforts that advocate for members through policy statements. Topics cover many areas including, but not limited to, the following areas of concern:
ASCP establishes the following issues as its current Patient-Centered Policy Priorities. The priorities represent a patient-centered agenda that will be advanced throughout the organization and provide guidance in science, technology, policy, and practice.
Download ASCP Policy Statements by clicking on titles below.